Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 118

    1.

    Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens.

    Asmuth DM, Brown EL, Dinubile MJ, Sun X, Del Rio C, Harro C, Keefer MC, Kublin JG, Dubey SA, Kierstead LS, Casimiro DR, Shiver JW, Robertson MN, Quirk EK, Mehrotra DV.

    J Infect Dis. 2010 Jan 1;201(1):132-41.PMID: 19929694 [PubMed - in process]Related articles

    3.

    Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.

    Lennox JL, DeJesus E, Lazzarin A, Pollard RB, Madruga JV, Berger DS, Zhao J, Xu X, Williams-Diaz A, Rodgers AJ, Barnard RJ, Miller MD, DiNubile MJ, Nguyen BY, Leavitt R, Sklar P; STARTMRK investigators.

    Lancet. 2009 Sep 5;374(9692):796-806. Epub 2009 Aug 3. Erratum in: Lancet. 2009 Sep 5;374(9692):786. PMID: 19647866 [PubMed - indexed for MEDLINE]Related articles

    4.

    Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults.

    Harro C, Sun X, Stek JE, Leavitt RY, Mehrotra DV, Wang F, Bett AJ, Casimiro DR, Shiver JW, DiNubile MJ, Quirk E; Merck V526-001 Study Group.

    Clin Vaccine Immunol. 2009 Sep;16(9):1285-92. Epub 2009 Jul 15.PMID: 19605598 [PubMed - indexed for MEDLINE]Related articles

    5.

    Understanding the high infectious disease mortality among patients receiving hemodialysis: Potential risk of concurrently low cathelicidin and gelsolin levels.

    DiNubile MJ.

    Clin Infect Dis. 2009 Jul 1;49(1):163-4; author reply 164-5. No abstract available. PMID: 19500030 [PubMed - indexed for MEDLINE]Related articles

    6.

    Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine.

    Clark HF, Lawley D, Mallette LA, DiNubile MJ, Hodinka RL.

    Clin Vaccine Immunol. 2009 Mar;16(3):382-6. Epub 2009 Jan 21.PMID: 19158283 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.

    Papasavvas E, Pistilli M, Reynolds G, Bucki R, Azzoni L, Chehimi J, Janmey PA, DiNubile MJ, Ondercin J, Kostman JR, Mounzer KC, Montaner LJ.

    AIDS. 2009 Jan 28;23(3):369-75.PMID: 19114856 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.

    Harro CD, Robertson MN, Lally MA, O'Neill LD, Edupuganti S, Goepfert PA, Mulligan MJ, Priddy FH, Dubey SA, Kierstead LS, Sun X, Casimiro DR, DiNubile MJ, Shiver JW, Leavitt RY, Mehrotra DV; Merck V520-007/012 Study Teams.

    AIDS Res Hum Retroviruses. 2009 Jan;25(1):103-14.PMID: 19108693 [PubMed - indexed for MEDLINE]Related articles

    9.

    Plasma gelsolin as a biomarker of inflammation.

    DiNubile MJ.

    Arthritis Res Ther. 2008;10(6):124. Epub 2008 Dec 3.PMID: 19105851 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Nonnucleotide reverse-transcriptase inhibitors and treatment interruption.

    DiNubile MJ.

    Clin Infect Dis. 2008 Dec 15;47(12):1602; author reply 1603. No abstract available. PMID: 19025367 [PubMed - indexed for MEDLINE]Related articles

    11.

    HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine.

    Quirk EK, Mogg R, Brown DD, Lally MA, Mehrotra DV, DiNubile MJ, Robertson MN.

    Clin Infect Dis. 2008 Dec 15;47(12):1593-9.PMID: 18990058 [PubMed - indexed for MEDLINE]Related articles

    12.

    Double-blind active-control trials: beware the comparator you keep.

    Dinubile MJ.

    Clin Infect Dis. 2008 Oct 15;47(8):1064-7.PMID: 18781878 [PubMed - indexed for MEDLINE]Related articles

    13.

    Nodular lymphangitis: a distinctive clinical entity with finite etiologies.

    Dinubile MJ.

    Curr Infect Dis Rep. 2008 Sep;10(5):404-10.PMID: 18687205 [PubMed - in process]Related articles

    14.

    Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

    Cooper DA, Steigbigel RT, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarin A, Clotet B, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Zhao J, Chen J, Ryan DM, Rhodes RR, Killar JA, Gilde LR, Strohmaier KM, Meibohm AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Teppler H, Nguyen BY; BENCHMRK Study Teams.

    N Engl J Med. 2008 Jul 24;359(4):355-65.PMID: 18650513 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Raltegravir with optimized background therapy for resistant HIV-1 infection.

    Steigbigel RT, Cooper DA, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarin A, Clotet B, Zhao J, Chen J, Ryan DM, Rhodes RR, Killar JA, Gilde LR, Strohmaier KM, Meibohm AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Nguyen BY, Teppler H; BENCHMRK Study Teams.

    N Engl J Med. 2008 Jul 24;359(4):339-54.PMID: 18650512 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency.

    Goveia MG, DiNubile MJ, Dallas MJ, Heaton PM, Kuter BJ; REST Study Team.

    Pediatr Infect Dis J. 2008 Jul;27(7):656-8.PMID: 18520448 [PubMed - indexed for MEDLINE]Related articles

    17.

    Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.

    Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM, Brown SJ, Kulkarni P, Dubey SA, Kierstead LS, Casimiro DR, Mogg R, DiNubile MJ, Shiver JW, Leavitt RY, Robertson MN, Mehrotra DV, Quirk E; Merck V520-016 Study Group.

    Clin Infect Dis. 2008 Jun 1;46(11):1769-81.PMID: 18433307 [PubMed - indexed for MEDLINE]Related articles

    18.

    Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infections.

    Dinubile MJ, Strohmaier KM, Lupinacci RJ, Meibohm AR, Sable CA, Kartsonis NA.

    Eur J Clin Microbiol Infect Dis. 2008 Aug;27(8):663-70. Epub 2008 Mar 7.PMID: 18324427 [PubMed - indexed for MEDLINE]Related articles

    19.

    Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.

    Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, DiNubile MJ; REST Study Team.

    Pediatr Infect Dis J. 2007 Dec;26(12):1099-104.PMID: 18043445 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy, safety, and tolerability of long-term combination antiretroviral therapy in asymptomatic treatment-naïve adults with early HIV infection.

    McMahon DK, Dinubile MJ, Meibohm AR, Marino DR, Robertson MN; for the Protocol 060 Study Group.

    HIV Clin Trials. 2007 Sep-Oct;8(5):269-81.PMID: 17956828 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.

    DiNubile MJ, Lupinacci RJ, Strohmaier KM, Sable CA, Kartsonis NA.

    J Crit Care. 2007 Sep;22(3):237-44. Epub 2007 Apr 10.PMID: 17869975 [PubMed - indexed for MEDLINE]Related articles

    22.

    Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.

    DiNubile MJ, Friedland IR, Chan CY, Motyl MR, Giezek H, McCarroll K, Shivaprakash M, Quinn JP, Weinstein RA, Chow JW.

    Diagn Microbiol Infect Dis. 2007 Aug;58(4):491-4. Epub 2007 May 16.PMID: 17509789 [PubMed - indexed for MEDLINE]Related articles

    23.

    Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States.

    Rodriguez ZM, Goveia MG, Stek JE, Dallas MJ, Boslego JW, DiNubile MJ, Heaton PM.

    Pediatr Infect Dis J. 2007 Mar;26(3):221-7.PMID: 17484218 [PubMed - indexed for MEDLINE]Related articles

    24.

    Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections.

    Navarro NS Jr, Campos MI, Alvarado R, Quintero N, Branicki FJ, Wei J, Shivaprakash M, Vrijens F, Giezek H, Chan CY, DiNubile MJ, Oasis II Study Team.

    Int J Surg. 2005;3(1):25-34.PMID: 17462256 [PubMed]Related articles

    25.
    26.

    In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

    Bochicchio GV, Baquero F, Hsueh PR, Paterson DL, Rossi F, Snyder TA, McCarroll K, Satishchandran V, Dinubile MJ, Chow JW.

    Surg Infect (Larchmt). 2006 Dec;7(6):537-45.PMID: 17233571 [PubMed - indexed for MEDLINE]Related articles

    27.

    Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.

    Yakovlev SV, Stratchounski LS, Woods GL, Adeyi B, McCarroll KA, Ginanni JA, Friedland IR, Wood CA, DiNubile MJ.

    Eur J Clin Microbiol Infect Dis. 2006 Oct;25(10):633-41.PMID: 17024505 [PubMed - indexed for MEDLINE]Related articles

    28.

    In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

    Hsueh PR, Snyder TA, Dinubile MJ, Satischandran V, McCarroll K, Chow JW; 2004 Asia-Pacific SMART Team.

    Int J Antimicrob Agents. 2006 Sep;28(3):238-43. Epub 2006 Aug 9. Erratum in: Int J Antimicrob Agents. 2009 Mar;33(3):295. PMID: 16904295 [PubMed - indexed for MEDLINE]Related articles

    29.

    Corticosteroids in ARDS.

    DiNubile MJ.

    N Engl J Med. 2006 Jul 20;355(3):317-8; author reply 318-9. No abstract available. PMID: 16856285 [PubMed - indexed for MEDLINE]Related articles

    30.

    Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States.

    Coffin SE, Elser J, Marchant C, Sawyer M, Pollara B, Fayorsey R, Nelson L, Lawley D, Goveia M, Stek J, Hille D, DiNubile MJ.

    Pediatr Infect Dis J. 2006 Jul;25(7):584-9.PMID: 16804426 [PubMed - indexed for MEDLINE]Related articles

    31.

    In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

    Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW.

    J Antimicrob Chemother. 2006 Jul;58(1):205-10. Epub 2006 May 22.PMID: 16717055 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.

    Dela Pena AS, Asperger W, Köckerling F, Raz R, Kafka R, Warren B, Shivaprakash M, Vrijens F, Giezek H, DiNubile MJ, Chan CY; Optimizing Intra-Abdominal Surgery with Invanz (OASIS)-I Study Group.

    J Gastrointest Surg. 2006 Apr;10(4):567-74.PMID: 16627223 [PubMed - indexed for MEDLINE]Related articles

    33.

    Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study.

    de Pauw BE, Sable CA, Walsh TJ, Lupinacci RJ, Bourque MR, Wise BA, Nguyen BY, DiNubile MJ, Teppler H.

    Transpl Infect Dis. 2006 Mar;8(1):31-7.PMID: 16623818 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.

    Vesikari T, Clark HF, Offit PA, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schödel F, Karvonen A, Drummond JE, DiNubile MJ, Heaton PM.

    Vaccine. 2006 May 29;24(22):4821-9. Epub 2006 Mar 31.PMID: 16621194 [PubMed - indexed for MEDLINE]Related articles

    35.

    Erectile dysfunction in an urban HIV-positive population.

    Ende AR, Lo Re V 3rd, DiNubile MJ, Mounzer K.

    AIDS Patient Care STDS. 2006 Feb;20(2):75-8.PMID: 16475887 [PubMed - indexed for MEDLINE]Related articles

    36.

    In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).

    Chow JW, Satishchandran V, Snyder TA, Harvey CM, Friedland IR, Dinubile MJ.

    Surg Infect (Larchmt). 2005 Winter;6(4):439-48.PMID: 16433608 [PubMed - indexed for MEDLINE]Related articles

    37.

    Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

    Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team.

    N Engl J Med. 2006 Jan 5;354(1):23-33.PMID: 16394299 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.

    DiNubile MJ, Chow JW, Satishchandran V, Polis A, Motyl MR, Abramson MA, Teppler H.

    Antimicrob Agents Chemother. 2005 Aug;49(8):3217-21.PMID: 16048928 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.

    Dinubile MJ, Friedland I, Chan CY, Motyl MR, Giezek H, Shivaprakash M, Weinstein RA, Quinn JP.

    Eur J Clin Microbiol Infect Dis. 2005 Jul;24(7):443-9.PMID: 15990986 [PubMed - indexed for MEDLINE]Related articles

    40.

    Invasive candidiasis in cancer patients: observations from a randomized clinical trial.

    DiNubile MJ, Hille D, Sable CA, Kartsonis NA.

    J Infect. 2005 Jun;50(5):443-9.PMID: 15907554 [PubMed - indexed for MEDLINE]Related articles

    41.

    In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).

    Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V, Snyder TA, Harvey CM, Teppler H, Dinubile MJ, Chow JW.

    J Antimicrob Chemother. 2005 Jun;55(6):965-73. Epub 2005 Apr 22.PMID: 15849262 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.

    Coplan PM, Cook JR, Carides GW, Heyse JF, Wu AW, Hammer SM, Nguyen BY, Meibohm AR, DiNubile MJ; AIDS Clinical Trials Group 320 Study Team.

    Clin Infect Dis. 2004 Aug 1;39(3):426-33. Epub 2004 Jul 19.PMID: 15307012 [PubMed - indexed for MEDLINE]Related articles

    43.

    Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia.

    Friedland IR, McCarroll KA, DiNubile MJ, Woods GL.

    Pulm Pharmacol Ther. 2004;17(4):199-203.PMID: 15219264 [PubMed - indexed for MEDLINE]Related articles

    44.

    Complicated infections of skin and skin structures: when the infection is more than skin deep.

    DiNubile MJ, Lipsky BA.

    J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii37-50. Review.PMID: 15150182 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.

    Nix DE, Majumdar AK, DiNubile MJ.

    J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii23-8. Review.PMID: 15150180 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.

    Hirsch MS, Steigbigel RT, Staszewski S, McMahon D, Fischl MA, Hirschel B, Squires K, DiNubile MJ, Harvey CM, Chen J, Leavitt RY; Protocol 039 Study Group.

    Clin Infect Dis. 2003 Oct 15;37(8):1119-24. Epub 2003 Sep 18.PMID: 14523778 [PubMed - indexed for MEDLINE]Related articles

    47.

    Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trials.

    Rojas C, Coplan PM, Rhodes T, Robertson MN, DiNubile MJ, Guess HA.

    Pharmacoepidemiol Drug Saf. 2003 Jul-Aug;12(5):361-9.PMID: 12899109 [PubMed - indexed for MEDLINE]Related articles

    48.

    Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.

    Coplan PM, Nikas A, Japour A, Cormier K, Maradit-Kremers H, Lewis R, Xu Y, DiNubile MJ.

    AIDS Res Hum Retroviruses. 2003 Jun;19(6):449-55.PMID: 12882653 [PubMed - indexed for MEDLINE]Related articles

    49.

    Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy.

    Saah AJ, Haas DW, DiNubile MJ, Chen J, Holder DJ, Rhodes RR, Shivaprakash M, Bakshi KK, Danovich RM, Graham DJ, Condra JH.

    J Infect Dis. 2003 Apr 1;187(7):1157-62. Epub 2003 Mar 19.PMID: 12660932 [PubMed - indexed for MEDLINE]Related articles

    50.

    Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults.

    Young B, Fischl MA, Wilson HM, Finn TS, Jensen EH, DiNubile MJ, Zeldin RK.

    J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):478-82.PMID: 12473835 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...